• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗心磷脂抗体及其相关临床病症的家族研究。

A family study of anticardiolipin antibodies and associated clinical conditions.

作者信息

Goldberg S N, Conti-Kelly A M, Greco T P

机构信息

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

出版信息

Am J Med. 1995 Nov;99(5):473-9. doi: 10.1016/s0002-9343(99)80222-8.

DOI:10.1016/s0002-9343(99)80222-8
PMID:7485203
Abstract

PURPOSE

To determine the frequency of anticardiolipin antibodies (aCL) and their clinical sequelae in family members of aCL-positive patients.

PATIENTS AND METHODS

A prospective serologic and clinical evaluation was performed on 23 patients with elevated aCL titers, 87 blood relatives, 18 spouses, and 37 controls. aCL and antinuclear antibodies (ANA) were measured and clinical histories were assessed for all probands, relatives, spouses, and controls.

RESULTS

Fifty of 87 relatives screened (57%) had evidence of autoantibody production (aCL and/or ANA). Twenty-nine (33%) had positive aCL titers. Twenty were positive for aCL-immunoglobulin (Ig) G, 7 had evidence of both aCL-IgG and aCL-IgM, and an additional 2 were positive for aCL-IgM alone. In contrast, only 1 spouse was aCL-IgG positive. Thirty-two relatives and 1 spouse were ANA positive. All controls were negative for aCL and ANA. Significant differences were noted between relatives and spouses for aCL-IgG (P < 0.00001) and aCL-IgM titers (P < 0.0066), and also between relatives and controls (P < 0.00001 for both). Clinically, 4 cases of systemic lupus erythematosus (SLE), 4 SLE-like diseases, and 8 aCL-associated illnesses (2 premature strokes, 3 recurrent fetal losses, 1 recurrent thrombosis, and 2 cases of thrombocytopenia) were documented in the relatives. All cases were associated with aCL and/or ANA production.

CONCLUSIONS

ANA, aCL, and clinical events associated with antiphospholipid antibodies occur with increased frequency in relatives, but not spouses of aCL-positive probands. These results suggest that aCL-related illnesses may be familial.

摘要

目的

确定抗心磷脂抗体(aCL)阳性患者家庭成员中抗心磷脂抗体的出现频率及其临床后遗症。

患者与方法

对23例aCL滴度升高的患者、87名血亲、18名配偶及37名对照者进行了前瞻性血清学和临床评估。检测了所有先证者、亲属、配偶及对照者的aCL和抗核抗体(ANA),并评估了其临床病史。

结果

87名接受筛查的亲属中有50名(57%)有自身抗体产生(aCL和/或ANA)的证据。29名(33%)aCL滴度呈阳性。20名aCL - 免疫球蛋白(Ig)G呈阳性,7名同时有aCL - IgG和aCL - IgM阳性的证据,另外2名仅aCL - IgM呈阳性。相比之下,仅1名配偶aCL - IgG呈阳性。32名亲属和1名配偶ANA呈阳性。所有对照者aCL和ANA均为阴性。亲属与配偶之间aCL - IgG(P < 0.00001)和aCL - IgM滴度(P < 0.0066)存在显著差异,亲属与对照者之间也存在显著差异(两者P均< 0.00001)。临床上,亲属中有4例系统性红斑狼疮(SLE)、4例类SLE疾病及8例与aCL相关的疾病(2例早发性中风、3例复发性流产、1例复发性血栓形成及2例血小板减少症)。所有病例均与aCL和/或ANA产生有关。

结论

抗核抗体、抗心磷脂抗体及与抗磷脂抗体相关的临床事件在aCL阳性先证者的亲属中出现频率增加,但在配偶中未增加。这些结果提示与aCL相关的疾病可能具有家族性。

相似文献

1
A family study of anticardiolipin antibodies and associated clinical conditions.抗心磷脂抗体及其相关临床病症的家族研究。
Am J Med. 1995 Nov;99(5):473-9. doi: 10.1016/s0002-9343(99)80222-8.
2
The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.一大群结缔组织病初发患者中抗心磷脂抗体的患病率及其临床关联
Am J Med. 1996 Dec;101(6):576-83. doi: 10.1016/s0002-9343(96)00335-x.
3
Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy.
Am J Med. 1997 Jul;103(1):33-7. doi: 10.1016/s0002-9343(97)90046-2.
4
Anti-cardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of SLE.复发性流产女性体内的抗心磷脂抗体(IgG和IgA)与系统性红斑狼疮的临床及血清学特征相关。
Acta Obstet Gynecol Scand. 1993 Aug;72(6):465-9. doi: 10.3109/00016349309021136.
5
Anticardiolipin and antinuclear antibodies in cancer patients--a case control study.
Clin Exp Rheumatol. 2000 Mar-Apr;18(2):227-32.
6
Anticardiolipin and antinuclear antibodies in the adult healthy Omani individuals.成年健康阿曼人群中的抗心磷脂抗体和抗核抗体。
Saudi Med J. 2004 Mar;25(3):313-7.
7
The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.系统性红斑狼疮患者抗心磷脂抗体的患病率及其与临床表现的关联。
Acta Med Iran. 2013;51(1):35-40.
8
Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.儿童期起病的系统性红斑狼疮:37例患者及其一级亲属中的抗磷脂抗体
Pediatrics. 1993 Dec;92(6):849-53.
9
Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.系统性红斑狼疮和抗磷脂综合征孕妇抗核抗体和抗心磷脂抗体的纵向研究
Rheumatol Int. 2002 Aug;22(4):142-7. doi: 10.1007/s00296-002-0207-x. Epub 2002 Jun 19.
10
Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus.抗心磷脂抗体在系统性红斑狼疮患者中识别血栓形成病史的准确性。
Am J Med. 1995 Jun;98(6):559-65. doi: 10.1016/s0002-9343(99)80014-x.

引用本文的文献

1
Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome.抗磷脂综合征的细胞和分子机制。
Front Immunol. 2018 May 7;9:969. doi: 10.3389/fimmu.2018.00969. eCollection 2018.
2
Pathophysiology of the antiphospholipid antibody syndrome.抗磷脂抗体综合征的病理生理学
Auto Immun Highlights. 2011 Mar 24;2(2):35-52. doi: 10.1007/s13317-011-0017-9. eCollection 2011 Nov.
3
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.《卒中一级预防指南:美国心脏协会/美国卒中协会给医疗保健专业人员的声明》
Stroke. 2014 Dec;45(12):3754-832. doi: 10.1161/STR.0000000000000046. Epub 2014 Oct 28.
4
Laboratory diagnosis of antiphospholipid antibodies.抗磷脂抗体的实验室诊断
Infect Dis Obstet Gynecol. 1997;5(2):181-2. doi: 10.1155/S1064744997000276.
5
Antiphospholipid syndrome: genetic review.抗磷脂综合征:遗传学综述
Curr Rheumatol Rep. 2003 Oct;5(5):391-4. doi: 10.1007/s11926-003-0030-8.
6
[Antiphospholipid antibody syndrome].[抗磷脂抗体综合征]
Med Klin (Munich). 1999 Feb 15;94(2):93-100. doi: 10.1007/BF03044707.